Taiwan on Monday approved the emergency use and production of a COVID-19 vaccine developed by Taiwanese firm Medigen Vaccine Biologics Corp. The vaccine candidate is yet to finish clinical trials and no efficacy data is available, according to Reuters. There were no major safety concerns during clinical trials of the vaccine in Taiwan, the country's Health Ministry said.